KI-6896

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameKI-6896
Drug Alias NameKI-6896
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsEpidermal growth factor receptor erbB1 inhibitors
TargetsPlatelet-derived growth factor receptorEpidermal growth factor receptor erbB1
Therapy Area/IndicationsGlomerulonephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKirin Brewery Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirin Brewery Company Ltd
Active IndicationsN/A
Inactive IndicationsGlomerulonephritis

Other Information

ATC CodeN/A
Related LinksN/A